Cover Image
市場調查報告書

社區性感染症:全球臨床實驗檢討

Community-Acquired Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320829
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
社區性感染症:全球臨床實驗檢討 Community-Acquired Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 73 Pages
簡介

社區性感染症,不是在醫療現場和住院中感染的感染疾病。許多情況下,社區性感染症,與在院內,影響從疾病和受傷回復的患者的微生物引起的疾病有區別。市內呼吸系統感染疾病,作用於流感菌和肺炎鏈球菌,通常對抗生素敏感。

本報告提供社區性感染症的治療藥相關臨床實驗調查分析、臨床實驗數及受驗人數、各階段及各方面狀況、有潛力的企業、正在開發的治療藥的資訊、臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東、非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:社區性感染症對感染性疾病臨床實驗的比例

G7各國的臨床實驗:各Phase

G7各國的臨床實驗:各階段

E7各國的臨床實驗:社區性感染症對感染性疾病臨床實驗的比例

E7各國的臨床實驗:各Phase

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

各評估項目臨床實驗

未完成的臨床實驗

一定期間採用的實驗對象

各贊助商類型臨床的實驗

有潛力的贊助商

  • 社區性感染症的治療藥參與臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Panacea Biotec Limited
    • 第一三共
    • Tetraphase Pharmaceuticals Inc.
    • TaiGen Biopharmaceuticals Holdings Limited
    • Janssen Research & Development, LLC
    • Dong Wha Pharma Co., Ltd.
    • Cubist Pharmaceuticals, Inc.
    • Belpharma S.A.
  • 主要大學、研究機關、醫院臨床實驗概要
    • Hanyang University Medical Center
    • Ewha Womans University
    • Kyungpook National University
    • Katholieke Universiteit Leuven
    • Rennes University Hospital
    • University of Milan

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2442CTIDB

GlobalData's clinical trial report, "Community-Acquired Infections Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Community-Acquired Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Community-Acquired Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Community-Acquired Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Panacea Biotec Limited
      • Clinical Trial Overview of Panacea Biotec Limited
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Tetraphase Pharmaceuticals Inc.
      • Clinical Trial Overview of Tetraphase Pharmaceuticals Inc.
      • TaiGen Biopharmaceuticals Holdings Limited
      • Clinical Trial Overview of TaiGen Biopharmaceuticals Holdings Limited
      • Janssen Research & Development, LLC
      • Clinical Trial Overview of Janssen Research & Development, LLC
      • Dong Wha Pharma Co., Ltd.
      • Clinical Trial Overview of Dong Wha Pharma Co., Ltd.
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Belpharma S.A.
      • Clinical Trial Overview of Belpharma S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • Hanyang University Medical Center
      • Clinical Trial Overview of Hanyang University Medical Center
      • Ewha Womans University
      • Clinical Trial Overview of Ewha Womans University
      • Kyungpook National University
      • Clinical Trial Overview of Kyungpook National University
      • Katholieke Universiteit Leuven
      • Clinical Trial Overview of Katholieke Universiteit Leuven
      • Rennes University Hospital
      • Clinical Trial Overview of Rennes University Hospital
      • University of Milan
      • Clinical Trial Overview of University of Milan
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Community-Acquired Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community-Acquired Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Community-Acquired Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community-Acquired Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tetraphase Pharmaceuticals Inc., 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research & Development, LLC, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Wha Pharma Co., Ltd., 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Belpharma S.A., 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanyang University Medical Center, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ewha Womans University, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyungpook National University, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014*

List of Figures

  • Community-Acquired Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Community-Acquired Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community-Acquired Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community-Acquired Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top